Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma

Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma—A case report

Published:2020-03-06 Issue:3 Volume:35 Page:227-230
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J Clin Apher

Author:

Gauckler Philipp¹^ORCID,Leierer Johannes¹,Kocher Florian²,Feistritzer Clemens²,Willenbacher Wolfgang²³,Gunsilius Eberhard²,Wolf Dominik²,Neuwirt Hannes¹,Mayer Gert¹,Kronbichler Andreas¹

Affiliation:

1. Department of Internal Medicine IV (Nephrology and Hypertension)Medical University Innsbruck Innsbruck Austria

2. Department of Internal Medicine V (Hematology and Oncology)Medical University Innsbruck Innsbruck Austria

3. Oncotyrol, Center for Personalized Cancer Medicine Innsbruck Austria

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jca.21775

Reference13 articles.

1. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

2. Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease

3. PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome

4. Lessons Learned from Checkpoint Blockade Targeting PD-1 in Multiple Myeloma

5. KEYTRUDA® (pembrolizumab) injection for intravenous use [prescribing information]. Kenilworth NJ: Merck Sharp & Dohme Corp; revised: 01/2020.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report;Translational Lung Cancer Research;2021-02